NCT07052916

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Pilot Trial of Telehealth Music Therapy for Cognitive Dysfunction in Hematologic Cancer Survivors (PRELUDE)

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Memorial Sloan Kettering Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Research has shown that music-based activities may help improve brain functions, such as attention, memory, and executive function. Because of this past research, the researchers are doing this study to find out whether telehealth music therapy is a practical treatment for cognitive difficulties in blood cancer survivors. The researchers will also study whether music therapy and music education help improve cognitive function and other common symptoms such as anxiety, depression, and/or tiredness.

Conditions

• Blood Cancer
• Lymphoma
• Leukemia
• Myeloma

Interventions

Type	Name	Description
OTHER	Music Therapy/MT	Therapeutic music lessons are the core component of the Music Therapy/MT intervention. Other components include guided music listening to help participants use music as a tool for regulating mood, energy, and attention, as well as music-centered discussions to help participants discover songs with personal meaning that they will enjoy learning to play.
OTHER	Therapist-Attention Music Education/TAME Control	Participants will receive 12, weekly 60-minute TAME sessions (+/- 1 week) with homework in-between sessions to reinforce in-session concepts and serve as transitions to subsequent sessions. The TAME control group will involve board-certified music therapists guiding participants through music listening exercises.

Timeline

• Start date: 2025-06-27
• Primary completion: 2026-12-27
• Completion: 2026-12-27
• First posted: 2025-07-08
• Last updated: 2025-07-11

Locations

7 sites across 1 country: United States